Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Orbem
Germany
- Munich, Bavaria
- 13/10/2023
- Series A
- $31,499,000
Unleashing AI-powered imaging for everything and everyone.
Orbem combines rapid magnetic resonance imaging with advanced deep learning to shed light on the world's toughest challenges. We are developing fast, accurate, and accessible imaging solutions that reveal hidden sources of knowledge.
In everything we do, we seek to make a difference – and are leveraging deep tech solutions to sustainably feed the world, accelerate the transition to a green economy, and transform disease detection.
Based on years of scientific research at the interface of AI and imaging technology, Orbem was founded in 2019 as a spin-off from the Technical University of Munich. Headquartered in Munich, our top tier, international, diverse, and multidisciplinary team is imagining new frontiers every single day to build a sustainable and healthy future.
Discover our first product, the Genus, at https://www.orbem.ai
Join our team anywhere in the world and shape the future of AI-powered imaging.
- Industry IT Services and IT Consulting
- Website https://orbem.ai/
- LinkedIn https://www.linkedin.com/company/orbem-ai/about/
Related People
Pedro GómezCo Founder
Germany -
Bavaria
Purpose-driven serial entrepreneur shedding light on the world's toughest challenges. At Orbem, we are energizing MRI with AI technology to make it accessible for everything and everyone. Discover more at: www.orbem.ai
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)